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To the Editor
It is with great interest that we read the letter by Dummula and Pandey [2] regarding the 
recent article entitled “False-Negative Pulse Oximetry Screening for Critical Congenital 
Heart Disease: The Case for Parent Education” [1]. Although much attention has been 
focused on children with a positive result (i.e., those who fail screening), little is known 
regarding children with a negative result (i.e., those who pass screening), particularly those 
with a false-negative result.
However, we wish to comment on a potential misconception regarding screening. In their 
letter, Dummula and Pandey urge the American Academy of Pediatrics “to mandate that 
nurseries document the cardiac conditions specifically ruled out by virtue of a negative 
screen on every discharge summary.” They suggest that pulse oximetry screening for critical 
congenital heart disease (CCHD) should be used to rule out the possibility of a child having 
certain types of CCHD due to the high specificity of the test.
Indeed, the specificity of pulse oximetry screening for CCHD is high at 99.9 % [95 % 
confidence interval (CI) 99.7–99.9 %]. However, the sensitivity, which is the more relevant 
measure for ruling out disease, is only 76.5 % (95 % CI 67.7–83.5 %) [4]. With this level of 
sensitivity, some cases of CCHD in newborns will still be missed before they are discharged 
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from the nursery. That is, there will be one child with CCHD with a false-negative result for 
approximately every three children with a true-positive result. This low sensitivity is most 
likely due to the fact that the onset and degree of hypoxemia may vary depending on the 
lesion and the individual [3].
What does this mean for clinical care? Until there is a screening test for CCHD that has 
close to 100 % sensitivity, we believe that pulse oximetry screening should be used as one 
additional tool to detect CCHD, but it should not preclude routine clinical examinations, nor 
should it be used to rule out heart disease, including any type of CCHD. For the newborn 
who presents to care with symptoms suggestive of CCHD, a full evaluation for the 
possibility of CCHD should be undertaken even if there is a history of a negative screening 
test because that result may represent a false-negative result.
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